Vericel Corp (VCEL) Financial Statements (2026 and earlier)

Company Profile

Business Address 64 SIDNEY ST.
CAMBRIDGE, MA 02139
State of Incorp. MI
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments137,499116,213109,557119,538103,39875,807
Cash and cash equivalent100,09274,52069,08851,06768,33033,620
Short-term investments37,40741,69340,46968,47135,06842,187
Restricted cash and investments  10,52917,778   
Receivables76,23455,97552,75640,43930,43729,204
Inventory, net of allowances, customer advances and progress billings17,56017,37313,08715,98613,3819,356
Inventory17,56017,37313,08715,98613,3819,356
Other current assets7,7447,2876,8534,8034,2463,893
Other undisclosed current assets8,4005,4005,6006,1007,0005,300
Total current assets:247,437212,777205,631186,866158,462123,560
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization686686 3773111
Operating lease, right-of-use asset64,77470,09873,46241,53545,72050,105
Long-term investments and receivables61,39539,88025,28319,96225,68724,099
Long-term investments61,39539,88025,28319,96225,68724,099
Intangible asset, including goodwill, after accumulated amortization5,6256,2506,8757,500  
Intangible asset, excluding goodwill, after accumulated amortization5,6256,2506,8757,500  
Restricted cash and investments  10,52917,778 211211
Other noncurrent assets3415567711,303317 
Other undisclosed noncurrent assets107,71191,94623,85715,80013,2357,522
Total noncurrent assets:240,532219,945148,02686,13785,24382,048
TOTAL ASSETS:487,969432,722353,657273,003243,705205,608
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities35,06440,91339,56233,12023,06118,048
Accounts payable15,82823,84822,34716,9309,0166,755
Accrued liabilities19,23617,06517,21516,19014,04511,293
Debt116116 414141
Other liabilities116116 414141
Other undisclosed current liabilities13,8539,1416,1874,2612,9094,353
Total current liabilities:49,14950,28645,74937,46326,05222,483
Noncurrent Liabilities
Long-term debt and lease obligation:     47,14748,789
Liabilities, other than long-term debt84,18090,46981,95643,2684476
Other liabilities1,896876100 4476
Operating lease, liability82,28489,59381,85643,26847,14748,789
Total noncurrent liabilities:84,18090,46981,95643,26847,19148,865
Total liabilities:133,329140,755127,70580,73173,24371,348
Equity
Equity, attributable to parent354,640291,967225,952192,272170,462134,260
Common stock730,662684,778629,229593,245553,902510,061
Accumulated other comprehensive income (loss)2754(100)(978)(154)14
Accumulated deficit(376,297)(392,815)(403,177)(399,995)(383,286)(375,815)
Total equity:354,640291,967225,952192,272170,462134,260
TOTAL LIABILITIES AND EQUITY:487,969432,722353,657273,003243,705205,608

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues276,259237,224197,516164,365156,184124,179
Cost of revenue
(Cost of Product and Service Sold)		(70,660)(65,117)(61,940)(54,577)(50,159)(39,951)
Gross profit:205,599172,107135,576109,788106,02584,228
Operating expenses(194,555)(167,588)(142,040)(126,846)(113,879)(81,856)
Operating income (loss):11,0444,519(6,464)(17,058)(7,854)2,372
Nonoperating income6,3335,9914,0961,070272672
Investment income, nonoperating7,0076,4104,6321,341224691
Other nonoperating income (expense)(44)195649552(6)
Interest and debt expense(630)(614)(600)(366)(4)(13)
Other undisclosed loss from continuing operations before equity method investments, income taxes      (167)
Income (loss) from continuing operations before equity method investments, income taxes:16,7479,896(2,968)(16,354)(7,586)2,864
Other undisclosed income from continuing operations before income taxes6306146003664180
Income (loss) from continuing operations before income taxes:17,37710,510(2,368)(15,988)(7,582)3,044
Income tax expense (benefit) (859)(148)(814)(721)111(180)
Other undisclosed loss from continuing operations      
Income (loss) from continuing operations:16,51810,362(3,182)(16,709)(7,471)2,864
Income (loss) before gain (loss) on sale of properties:✕✕✕✕✕(7,471)2,864
Net income (loss):16,51810,362(3,182)(16,709)(7,471)2,864
Other undisclosed net income attributable to parent      
Net income (loss) available to common stockholders, diluted:16,51810,362(3,182)(16,709)(7,471)2,864

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net income (loss):16,51810,362(3,182)(16,709)(7,471)2,864
Comprehensive income (loss):16,51810,362(3,182)(16,709)(7,471)2,864
Other undisclosed comprehensive income (loss), net of tax, attributable to parent271104878(824)(168)(7)
Comprehensive income (loss), net of tax, attributable to parent:16,78910,466(2,304)(17,533)(7,639)2,857

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: